Stockreport

AstraZeneca's Tagrisso plus chemotherapy wins EU approval for NSCLC [Yahoo! Finance]

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF cancer (NSCLC) patients with epidermal growth factor receptor mutations (EGFRm) in adults. The tyrosine kinase inhibitor has been approved alongside pemetrexed and pla [Read more]